Christian Hopfer
Concepts (403)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Substance-Related Disorders | 36 | 2023 | 1022 | 3.670 |
Why?
| | Marijuana Abuse | 21 | 2024 | 233 | 3.560 |
Why?
| | Cannabis | 12 | 2024 | 461 | 3.040 |
Why?
| | Conduct Disorder | 16 | 2023 | 199 | 2.140 |
Why?
| | Marijuana Use | 8 | 2024 | 191 | 1.710 |
Why?
| | Adolescent Behavior | 16 | 2020 | 507 | 1.510 |
Why?
| | Alcohol Drinking | 16 | 2024 | 764 | 1.480 |
Why?
| | Marijuana Smoking | 9 | 2022 | 247 | 1.400 |
Why?
| | Alcoholism | 19 | 2023 | 764 | 1.350 |
Why?
| | Social Environment | 10 | 2014 | 293 | 1.180 |
Why?
| | Tobacco Use Disorder | 11 | 2020 | 237 | 1.150 |
Why?
| | Adolescent | 92 | 2024 | 20409 | 1.090 |
Why?
| | Polymorphism, Single Nucleotide | 21 | 2022 | 2062 | 1.090 |
Why?
| | Antisocial Personality Disorder | 15 | 2018 | 163 | 1.070 |
Why?
| | Genetic Predisposition to Disease | 16 | 2022 | 2271 | 0.990 |
Why?
| | Smoking | 17 | 2019 | 1501 | 0.850 |
Why?
| | Twins | 9 | 2024 | 247 | 0.820 |
Why?
| | Siblings | 12 | 2020 | 216 | 0.800 |
Why?
| | Medical Marijuana | 3 | 2020 | 111 | 0.790 |
Why?
| | Analgesics, Opioid | 7 | 2020 | 919 | 0.740 |
Why?
| | Risk-Taking | 7 | 2019 | 348 | 0.720 |
Why?
| | Genome-Wide Association Study | 14 | 2022 | 1326 | 0.710 |
Why?
| | Legislation, Drug | 4 | 2023 | 77 | 0.700 |
Why?
| | Diagnostic and Statistical Manual of Mental Disorders | 10 | 2018 | 235 | 0.670 |
Why?
| | Young Adult | 37 | 2023 | 12438 | 0.670 |
Why?
| | Dronabinol | 2 | 2020 | 203 | 0.670 |
Why?
| | Problem Behavior | 2 | 2018 | 93 | 0.660 |
Why?
| | Humans | 124 | 2024 | 129527 | 0.660 |
Why?
| | Female | 94 | 2023 | 68650 | 0.660 |
Why?
| | Opioid-Related Disorders | 5 | 2021 | 484 | 0.650 |
Why?
| | Colorado | 23 | 2022 | 4403 | 0.650 |
Why?
| | Male | 92 | 2023 | 63586 | 0.650 |
Why?
| | Cannabinol | 1 | 2019 | 2 | 0.630 |
Why?
| | Diseases in Twins | 4 | 2014 | 175 | 0.610 |
Why?
| | Homeless Youth | 3 | 2008 | 18 | 0.600 |
Why?
| | Hallucinogens | 1 | 2020 | 102 | 0.590 |
Why?
| | Adult | 58 | 2024 | 35505 | 0.580 |
Why?
| | Criminals | 1 | 2018 | 36 | 0.570 |
Why?
| | Substance Abuse, Intravenous | 3 | 2016 | 109 | 0.570 |
Why?
| | Mental Disorders | 8 | 2021 | 1026 | 0.570 |
Why?
| | Heroin Dependence | 3 | 2003 | 31 | 0.560 |
Why?
| | Colitis, Ulcerative | 1 | 2019 | 120 | 0.560 |
Why?
| | Longitudinal Studies | 25 | 2024 | 2724 | 0.550 |
Why?
| | Prescription Drug Misuse | 1 | 2017 | 40 | 0.550 |
Why?
| | Sexual Behavior | 5 | 2019 | 481 | 0.550 |
Why?
| | Cigarette Smoking | 1 | 2018 | 91 | 0.540 |
Why?
| | Receptors, Nicotinic | 7 | 2016 | 329 | 0.530 |
Why?
| | Genetic Linkage | 3 | 2008 | 296 | 0.510 |
Why?
| | Prevalence | 11 | 2022 | 2561 | 0.500 |
Why?
| | Prescription Drug Diversion | 1 | 2016 | 12 | 0.500 |
Why?
| | Crohn Disease | 1 | 2019 | 217 | 0.490 |
Why?
| | Genotype | 15 | 2019 | 1827 | 0.470 |
Why?
| | Motivation | 2 | 2018 | 547 | 0.440 |
Why?
| | Accidents, Traffic | 2 | 2018 | 184 | 0.430 |
Why?
| | Inflammatory Bowel Diseases | 1 | 2018 | 326 | 0.420 |
Why?
| | Receptors, Dopamine D2 | 4 | 2007 | 91 | 0.420 |
Why?
| | Body Mass Index | 3 | 2018 | 2269 | 0.420 |
Why?
| | Family Health | 1 | 2014 | 198 | 0.400 |
Why?
| | Polymorphism, Genetic | 4 | 2016 | 636 | 0.390 |
Why?
| | Genetic Variation | 5 | 2022 | 936 | 0.380 |
Why?
| | Comorbidity | 9 | 2016 | 1548 | 0.330 |
Why?
| | Phenotype | 14 | 2020 | 3058 | 0.330 |
Why?
| | Surveys and Questionnaires | 13 | 2019 | 5429 | 0.330 |
Why?
| | Urban Population | 2 | 2012 | 442 | 0.320 |
Why?
| | Child Abuse | 6 | 2021 | 513 | 0.320 |
Why?
| | Substance Abuse Detection | 2 | 2020 | 79 | 0.320 |
Why?
| | Biological Specimen Banks | 4 | 2019 | 96 | 0.320 |
Why?
| | Prospective Studies | 9 | 2020 | 7150 | 0.320 |
Why?
| | Nurses, Community Health | 2 | 2019 | 28 | 0.320 |
Why?
| | Impulsive Behavior | 4 | 2017 | 127 | 0.310 |
Why?
| | Substance Withdrawal Syndrome | 2 | 2019 | 175 | 0.310 |
Why?
| | United Kingdom | 3 | 2019 | 257 | 0.310 |
Why?
| | Prenatal Care | 3 | 2019 | 277 | 0.310 |
Why?
| | United States | 17 | 2022 | 13865 | 0.300 |
Why?
| | Criminal Behavior | 2 | 2018 | 6 | 0.300 |
Why?
| | Haplotypes | 5 | 2009 | 474 | 0.300 |
Why?
| | House Calls | 2 | 2019 | 124 | 0.290 |
Why?
| | Attention Deficit Disorder with Hyperactivity | 5 | 2022 | 394 | 0.290 |
Why?
| | Juvenile Delinquency | 5 | 2018 | 109 | 0.290 |
Why?
| | Cognition | 4 | 2020 | 1125 | 0.280 |
Why?
| | Adolescent Development | 2 | 2019 | 84 | 0.280 |
Why?
| | Genetic Association Studies | 4 | 2021 | 357 | 0.280 |
Why?
| | Sex Factors | 10 | 2017 | 1966 | 0.270 |
Why?
| | Chromosomes, Human, Pair 9 | 1 | 2006 | 40 | 0.270 |
Why?
| | Receptors, Cannabinoid | 1 | 2006 | 15 | 0.270 |
Why?
| | Chromosomes, Human, Pair 3 | 1 | 2006 | 48 | 0.270 |
Why?
| | Case-Control Studies | 10 | 2019 | 3383 | 0.260 |
Why?
| | Health Surveys | 5 | 2012 | 493 | 0.260 |
Why?
| | Multifactorial Inheritance | 3 | 2022 | 150 | 0.260 |
Why?
| | Analgesics | 2 | 2020 | 194 | 0.260 |
Why?
| | Home Care Services | 2 | 2019 | 244 | 0.260 |
Why?
| | Multigene Family | 3 | 2013 | 195 | 0.260 |
Why?
| | Drug Prescriptions | 2 | 2018 | 242 | 0.250 |
Why?
| | Homosexuality | 1 | 2006 | 16 | 0.250 |
Why?
| | Cross-Sectional Studies | 8 | 2018 | 5078 | 0.250 |
Why?
| | Registries | 1 | 2014 | 1902 | 0.250 |
Why?
| | Mothers | 3 | 2019 | 731 | 0.250 |
Why?
| | Bisexuality | 1 | 2006 | 30 | 0.250 |
Why?
| | Receptors, Dopamine D1 | 1 | 2006 | 29 | 0.250 |
Why?
| | Tandem Mass Spectrometry | 2 | 2020 | 525 | 0.250 |
Why?
| | Tobacco Use | 2 | 2024 | 61 | 0.240 |
Why?
| | Research Subjects | 2 | 2015 | 42 | 0.230 |
Why?
| | Aggression | 4 | 2022 | 201 | 0.230 |
Why?
| | Environment | 5 | 2012 | 345 | 0.230 |
Why?
| | Substance Abuse Treatment Centers | 3 | 2012 | 40 | 0.230 |
Why?
| | Genome | 1 | 2006 | 278 | 0.230 |
Why?
| | Linkage Disequilibrium | 7 | 2021 | 257 | 0.220 |
Why?
| | Genomics | 3 | 2020 | 715 | 0.220 |
Why?
| | Child Behavior Disorders | 3 | 2011 | 136 | 0.220 |
Why?
| | Age of Onset | 5 | 2018 | 495 | 0.220 |
Why?
| | Internationality | 2 | 2022 | 150 | 0.210 |
Why?
| | Obesity | 1 | 2017 | 2875 | 0.210 |
Why?
| | Twins, Monozygotic | 5 | 2010 | 209 | 0.210 |
Why?
| | Interview, Psychological | 4 | 2013 | 95 | 0.210 |
Why?
| | Alleles | 8 | 2018 | 843 | 0.210 |
Why?
| | Child | 23 | 2022 | 20932 | 0.210 |
Why?
| | Gene Frequency | 6 | 2016 | 500 | 0.210 |
Why?
| | Genetic Loci | 3 | 2022 | 274 | 0.210 |
Why?
| | Adoption | 1 | 2003 | 32 | 0.210 |
Why?
| | Narcotics | 1 | 2003 | 45 | 0.200 |
Why?
| | Heroin | 1 | 2003 | 30 | 0.200 |
Why?
| | Models, Genetic | 6 | 2010 | 592 | 0.200 |
Why?
| | Nerve Tissue Proteins | 5 | 2013 | 569 | 0.200 |
Why?
| | Risk Factors | 12 | 2022 | 9779 | 0.200 |
Why?
| | Serotonin Plasma Membrane Transport Proteins | 2 | 2016 | 74 | 0.190 |
Why?
| | Incidence | 4 | 2018 | 2643 | 0.190 |
Why?
| | Age Factors | 6 | 2014 | 3150 | 0.180 |
Why?
| | Public Health | 1 | 2006 | 484 | 0.180 |
Why?
| | Attention Deficit and Disruptive Behavior Disorders | 2 | 2013 | 61 | 0.180 |
Why?
| | Cannabinoid Receptor Agonists | 1 | 2020 | 46 | 0.170 |
Why?
| | Monoamine Oxidase | 2 | 2013 | 27 | 0.160 |
Why?
| | Health Risk Behaviors | 1 | 2019 | 16 | 0.160 |
Why?
| | Autistic Disorder | 1 | 2022 | 185 | 0.160 |
Why?
| | Sleep Initiation and Maintenance Disorders | 1 | 2022 | 153 | 0.160 |
Why?
| | Maternal Health | 1 | 2019 | 45 | 0.160 |
Why?
| | Nausea | 1 | 2020 | 111 | 0.160 |
Why?
| | Depression | 3 | 2022 | 1321 | 0.160 |
Why?
| | Pain, Postoperative | 2 | 2019 | 244 | 0.160 |
Why?
| | Twins, Dizygotic | 4 | 2010 | 181 | 0.160 |
Why?
| | Behavior, Addictive | 1 | 2020 | 81 | 0.160 |
Why?
| | Minisatellite Repeats | 1 | 2019 | 40 | 0.150 |
Why?
| | Physician Incentive Plans | 1 | 2018 | 6 | 0.150 |
Why?
| | Expressed Emotion | 1 | 2018 | 18 | 0.150 |
Why?
| | HIV Infections | 1 | 2013 | 2729 | 0.150 |
Why?
| | Middle Aged | 13 | 2023 | 31087 | 0.150 |
Why?
| | Calcium-Transporting ATPases | 1 | 2018 | 40 | 0.150 |
Why?
| | Mortality, Premature | 1 | 2018 | 12 | 0.150 |
Why?
| | Multimodal Imaging | 1 | 2019 | 110 | 0.150 |
Why?
| | Chromatography, Liquid | 1 | 2020 | 424 | 0.150 |
Why?
| | Digestive System Surgical Procedures | 1 | 2019 | 98 | 0.150 |
Why?
| | Pregnancy | 5 | 2022 | 6412 | 0.140 |
Why?
| | Feeding and Eating Disorders | 1 | 2020 | 146 | 0.140 |
Why?
| | Analgesics, Non-Narcotic | 1 | 2019 | 122 | 0.140 |
Why?
| | Biomedical Research | 2 | 2014 | 639 | 0.140 |
Why?
| | Urine | 1 | 2017 | 60 | 0.140 |
Why?
| | Cannabinoids | 2 | 2017 | 154 | 0.140 |
Why?
| | Bioethics | 1 | 2017 | 14 | 0.140 |
Why?
| | Receptors, Opioid, mu | 2 | 2015 | 66 | 0.140 |
Why?
| | Unsafe Sex | 2 | 2016 | 59 | 0.130 |
Why?
| | Physicians, Family | 1 | 2018 | 205 | 0.130 |
Why?
| | Neuropsychological Tests | 2 | 2020 | 1011 | 0.130 |
Why?
| | Infant, Newborn | 4 | 2020 | 5769 | 0.130 |
Why?
| | Suicide | 2 | 2021 | 613 | 0.130 |
Why?
| | Administration, Oral | 1 | 2019 | 783 | 0.130 |
Why?
| | Gene-Environment Interaction | 2 | 2020 | 185 | 0.130 |
Why?
| | Lipids | 1 | 2020 | 614 | 0.130 |
Why?
| | Counseling | 1 | 2020 | 383 | 0.130 |
Why?
| | Depressive Disorder, Major | 2 | 2020 | 344 | 0.130 |
Why?
| | Receptors, Metabotropic Glutamate | 1 | 2016 | 40 | 0.130 |
Why?
| | Brain | 2 | 2019 | 2675 | 0.130 |
Why?
| | Patient Admission | 2 | 2012 | 183 | 0.120 |
Why?
| | Plasma | 1 | 2017 | 206 | 0.120 |
Why?
| | Mental Competency | 1 | 2015 | 25 | 0.120 |
Why?
| | Drug Storage | 1 | 2016 | 58 | 0.120 |
Why?
| | Self Report | 2 | 2018 | 800 | 0.120 |
Why?
| | Mental Health | 1 | 2022 | 687 | 0.120 |
Why?
| | Brain Mapping | 1 | 2019 | 575 | 0.120 |
Why?
| | Surgical Procedures, Operative | 1 | 2018 | 242 | 0.120 |
Why?
| | Drug Overdose | 2 | 2018 | 326 | 0.120 |
Why?
| | Interviews as Topic | 3 | 2007 | 707 | 0.120 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2019 | 739 | 0.120 |
Why?
| | Exploratory Behavior | 2 | 2013 | 87 | 0.120 |
Why?
| | Neuroimaging | 1 | 2017 | 279 | 0.120 |
Why?
| | Life Change Events | 1 | 2016 | 149 | 0.120 |
Why?
| | Informed Consent | 1 | 2015 | 165 | 0.110 |
Why?
| | Aged | 6 | 2018 | 22063 | 0.110 |
Why?
| | Pregnancy Complications | 1 | 2019 | 493 | 0.110 |
Why?
| | Automobile Driving | 1 | 2016 | 140 | 0.110 |
Why?
| | Patient Satisfaction | 1 | 2018 | 636 | 0.110 |
Why?
| | Medicine | 1 | 2016 | 117 | 0.110 |
Why?
| | Practice Patterns, Physicians' | 3 | 2019 | 1257 | 0.110 |
Why?
| | Cohort Studies | 6 | 2021 | 5423 | 0.110 |
Why?
| | Netherlands | 1 | 2014 | 77 | 0.110 |
Why?
| | Time Factors | 3 | 2019 | 6530 | 0.110 |
Why?
| | Regression Analysis | 3 | 2019 | 994 | 0.110 |
Why?
| | Proteomics | 1 | 2020 | 1053 | 0.110 |
Why?
| | Genetic Testing | 1 | 2016 | 422 | 0.110 |
Why?
| | Receptors, GABA-A | 1 | 2014 | 125 | 0.100 |
Why?
| | Conflict of Interest | 1 | 2014 | 123 | 0.100 |
Why?
| | Temperament | 1 | 2013 | 46 | 0.100 |
Why?
| | Condoms | 1 | 2013 | 104 | 0.100 |
Why?
| | Patient Safety | 1 | 2016 | 287 | 0.100 |
Why?
| | Emotions | 2 | 2021 | 545 | 0.100 |
Why?
| | Severity of Illness Index | 2 | 2019 | 2734 | 0.100 |
Why?
| | Receptors, Oxytocin | 1 | 2012 | 22 | 0.100 |
Why?
| | Family Conflict | 1 | 2012 | 40 | 0.090 |
Why?
| | Socioeconomic Factors | 2 | 2013 | 1211 | 0.090 |
Why?
| | Sexual Partners | 1 | 2013 | 185 | 0.090 |
Why?
| | Family Relations | 1 | 2012 | 87 | 0.090 |
Why?
| | Multivariate Analysis | 2 | 2012 | 1491 | 0.090 |
Why?
| | Educational Status | 1 | 2013 | 469 | 0.090 |
Why?
| | Ethanol | 2 | 2012 | 591 | 0.080 |
Why?
| | Logistic Models | 4 | 2019 | 1983 | 0.080 |
Why?
| | Pentachlorophenol | 1 | 1990 | 22 | 0.080 |
Why?
| | Dizziness | 1 | 2010 | 80 | 0.080 |
Why?
| | Psychometrics | 3 | 2009 | 696 | 0.080 |
Why?
| | Models, Statistical | 2 | 2010 | 624 | 0.080 |
Why?
| | Hospitalization | 1 | 2019 | 2076 | 0.080 |
Why?
| | Models, Theoretical | 1 | 2013 | 548 | 0.080 |
Why?
| | Sample Size | 2 | 2022 | 116 | 0.080 |
Why?
| | Genetic Markers | 2 | 2007 | 334 | 0.080 |
Why?
| | Magnetic Resonance Imaging | 2 | 2019 | 3392 | 0.080 |
Why?
| | Receptor, Cannabinoid, CB1 | 1 | 2009 | 40 | 0.080 |
Why?
| | Biomarkers | 1 | 2020 | 3968 | 0.080 |
Why?
| | Taq Polymerase | 2 | 2006 | 10 | 0.080 |
Why?
| | Suicidal Ideation | 3 | 2021 | 493 | 0.070 |
Why?
| | Child Abuse, Sexual | 1 | 2009 | 89 | 0.070 |
Why?
| | Primary Health Care | 1 | 2018 | 1677 | 0.070 |
Why?
| | Emergency Service, Hospital | 1 | 2019 | 1918 | 0.070 |
Why?
| | Retrospective Studies | 8 | 2021 | 14532 | 0.070 |
Why?
| | Disruptive, Impulse Control, and Conduct Disorders | 1 | 2007 | 10 | 0.070 |
Why?
| | Stress, Psychological | 1 | 2016 | 1067 | 0.070 |
Why?
| | Methylphenidate | 2 | 2004 | 36 | 0.070 |
Why?
| | Deoxyribonucleases, Type II Site-Specific | 1 | 2007 | 15 | 0.070 |
Why?
| | Polymorphism, Restriction Fragment Length | 1 | 2007 | 66 | 0.070 |
Why?
| | Quality of Life | 1 | 2019 | 2694 | 0.070 |
Why?
| | Statistics as Topic | 1 | 2008 | 305 | 0.070 |
Why?
| | Risk | 2 | 2020 | 857 | 0.070 |
Why?
| | Family | 4 | 2016 | 645 | 0.070 |
Why?
| | Schizophrenia | 2 | 2022 | 425 | 0.070 |
Why?
| | 3' Untranslated Regions | 1 | 2007 | 137 | 0.060 |
Why?
| | Child of Impaired Parents | 1 | 2006 | 40 | 0.060 |
Why?
| | Cheek | 1 | 2006 | 15 | 0.060 |
Why?
| | Fathers | 1 | 2006 | 50 | 0.060 |
Why?
| | Lysergic Acid Diethylamide | 1 | 2006 | 2 | 0.060 |
Why?
| | Social Facilitation | 1 | 2006 | 10 | 0.060 |
Why?
| | Sodium Oxybate | 1 | 2006 | 4 | 0.060 |
Why?
| | N-Methyl-3,4-methylenedioxyamphetamine | 1 | 2006 | 10 | 0.060 |
Why?
| | Central Nervous System Stimulants | 2 | 2004 | 149 | 0.060 |
Why?
| | Microsatellite Repeats | 1 | 2006 | 163 | 0.060 |
Why?
| | Genetics, Population | 1 | 2007 | 200 | 0.060 |
Why?
| | Alcohol-Related Disorders | 1 | 2007 | 118 | 0.060 |
Why?
| | Poverty | 2 | 2019 | 497 | 0.060 |
Why?
| | Protein Kinase C | 1 | 2007 | 261 | 0.060 |
Why?
| | Religion | 1 | 2006 | 67 | 0.060 |
Why?
| | Parenting | 1 | 2009 | 294 | 0.060 |
Why?
| | Parents | 2 | 2004 | 1309 | 0.060 |
Why?
| | Methamphetamine | 1 | 2006 | 54 | 0.060 |
Why?
| | Confidence Intervals | 2 | 2006 | 316 | 0.060 |
Why?
| | Ketamine | 1 | 2006 | 89 | 0.060 |
Why?
| | Beta Rhythm | 1 | 2004 | 19 | 0.060 |
Why?
| | Suicide, Attempted | 1 | 2008 | 356 | 0.060 |
Why?
| | Universities | 1 | 2007 | 406 | 0.060 |
Why?
| | Pain Management | 2 | 2019 | 330 | 0.060 |
Why?
| | Treatment Outcome | 3 | 2019 | 10232 | 0.050 |
Why?
| | Marriage | 1 | 2004 | 116 | 0.050 |
Why?
| | Data Interpretation, Statistical | 3 | 2010 | 337 | 0.050 |
Why?
| | Drug Tolerance | 1 | 2003 | 89 | 0.050 |
Why?
| | Genome, Human | 2 | 2020 | 393 | 0.050 |
Why?
| | Infant | 3 | 2021 | 9005 | 0.050 |
Why?
| | Membrane Transport Proteins | 1 | 2003 | 149 | 0.050 |
Why?
| | Europe | 1 | 2022 | 362 | 0.050 |
Why?
| | Loneliness | 1 | 2022 | 39 | 0.050 |
Why?
| | Sensitivity and Specificity | 2 | 2021 | 1842 | 0.050 |
Why?
| | Methadone | 1 | 2002 | 92 | 0.050 |
Why?
| | Predictive Value of Tests | 2 | 2021 | 1950 | 0.050 |
Why?
| | Models, Psychological | 2 | 2016 | 308 | 0.050 |
Why?
| | Personality Assessment | 2 | 2013 | 81 | 0.040 |
Why?
| | Calibration | 1 | 2021 | 140 | 0.040 |
Why?
| | Membrane Glycoproteins | 1 | 2003 | 477 | 0.040 |
Why?
| | Proportional Hazards Models | 2 | 2018 | 1196 | 0.040 |
Why?
| | Electroencephalography | 1 | 2003 | 409 | 0.040 |
Why?
| | Follow-Up Studies | 2 | 2019 | 4891 | 0.040 |
Why?
| | Polymerase Chain Reaction | 2 | 2014 | 1031 | 0.040 |
Why?
| | Bayes Theorem | 1 | 2021 | 374 | 0.040 |
Why?
| | Bipolar Disorder | 1 | 2022 | 235 | 0.040 |
Why?
| | Minnesota | 1 | 2020 | 149 | 0.040 |
Why?
| | Interrupted Time Series Analysis | 1 | 2019 | 54 | 0.040 |
Why?
| | Drug Utilization Review | 1 | 2019 | 55 | 0.040 |
Why?
| | Dangerous Behavior | 1 | 2018 | 19 | 0.040 |
Why?
| | Diffusion Magnetic Resonance Imaging | 1 | 2019 | 98 | 0.040 |
Why?
| | Infant, Small for Gestational Age | 1 | 2019 | 84 | 0.040 |
Why?
| | Signal Processing, Computer-Assisted | 1 | 2019 | 144 | 0.040 |
Why?
| | Electronic Mail | 1 | 2018 | 60 | 0.040 |
Why?
| | Atmospheric Pressure | 1 | 2017 | 23 | 0.040 |
Why?
| | Safety-net Providers | 1 | 2019 | 110 | 0.040 |
Why?
| | Statistics, Nonparametric | 2 | 2012 | 422 | 0.040 |
Why?
| | Preoperative Period | 1 | 2018 | 116 | 0.040 |
Why?
| | Factor Analysis, Statistical | 2 | 2010 | 282 | 0.040 |
Why?
| | Tobacco Products | 1 | 2019 | 110 | 0.040 |
Why?
| | Limit of Detection | 1 | 2017 | 83 | 0.030 |
Why?
| | Epidemics | 1 | 2018 | 82 | 0.030 |
Why?
| | Child, Preschool | 2 | 2022 | 10499 | 0.030 |
Why?
| | Gene Expression | 2 | 2016 | 1461 | 0.030 |
Why?
| | Executive Function | 1 | 2021 | 429 | 0.030 |
Why?
| | Postoperative Period | 1 | 2018 | 329 | 0.030 |
Why?
| | Pregnancy Outcome | 1 | 2019 | 391 | 0.030 |
Why?
| | Transcriptome | 1 | 2022 | 875 | 0.030 |
Why?
| | Psychiatric Status Rating Scales | 2 | 2010 | 533 | 0.030 |
Why?
| | Chromosome Mapping | 2 | 2008 | 499 | 0.030 |
Why?
| | Cause of Death | 1 | 2018 | 395 | 0.030 |
Why?
| | California | 1 | 2017 | 393 | 0.030 |
Why?
| | Nicotine | 2 | 2010 | 304 | 0.030 |
Why?
| | Mortality | 1 | 2018 | 306 | 0.030 |
Why?
| | CD56 Antigen | 1 | 2016 | 36 | 0.030 |
Why?
| | Quality Control | 1 | 2016 | 161 | 0.030 |
Why?
| | Violence | 1 | 2018 | 244 | 0.030 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2017 | 584 | 0.030 |
Why?
| | Practice Guidelines as Topic | 1 | 2003 | 1510 | 0.030 |
Why?
| | Potassium Channels | 1 | 2016 | 149 | 0.030 |
Why?
| | Reward | 1 | 2017 | 243 | 0.030 |
Why?
| | Sleep | 1 | 2021 | 688 | 0.030 |
Why?
| | Heterozygote | 1 | 2016 | 270 | 0.030 |
Why?
| | Psychology, Adolescent | 1 | 2015 | 65 | 0.030 |
Why?
| | Thoracic Surgical Procedures | 1 | 2016 | 70 | 0.030 |
Why?
| | Anxiety | 1 | 2022 | 976 | 0.030 |
Why?
| | Cell Adhesion Molecules | 1 | 2016 | 173 | 0.030 |
Why?
| | Sexually Transmitted Diseases | 1 | 2016 | 150 | 0.030 |
Why?
| | Likelihood Functions | 1 | 2015 | 137 | 0.030 |
Why?
| | Aging | 1 | 2004 | 1770 | 0.030 |
Why?
| | Demography | 1 | 2015 | 279 | 0.030 |
Why?
| | Cesarean Section | 1 | 2016 | 183 | 0.030 |
Why?
| | Disclosure | 1 | 2014 | 110 | 0.030 |
Why?
| | Arsenites | 1 | 1993 | 5 | 0.030 |
Why?
| | Arsenic Poisoning | 1 | 1993 | 7 | 0.030 |
Why?
| | Risk Assessment | 2 | 2015 | 3255 | 0.030 |
Why?
| | Cotinine | 1 | 2013 | 75 | 0.030 |
Why?
| | Chelating Agents | 1 | 1993 | 69 | 0.030 |
Why?
| | Arsenicals | 1 | 1993 | 30 | 0.030 |
Why?
| | Gluconeogenesis | 1 | 1993 | 78 | 0.030 |
Why?
| | Academic Medical Centers | 1 | 2016 | 478 | 0.030 |
Why?
| | Child Behavior | 2 | 2005 | 235 | 0.020 |
Why?
| | Databases, Factual | 1 | 2018 | 1261 | 0.020 |
Why?
| | Kidney Tubules | 1 | 1993 | 114 | 0.020 |
Why?
| | Psychological Theory | 1 | 2013 | 98 | 0.020 |
Why?
| | Probability | 1 | 2013 | 302 | 0.020 |
Why?
| | Privacy | 1 | 2012 | 33 | 0.020 |
Why?
| | Students | 1 | 2017 | 581 | 0.020 |
Why?
| | Carrier Proteins | 1 | 2016 | 740 | 0.020 |
Why?
| | Pedigree | 1 | 2013 | 482 | 0.020 |
Why?
| | Antidotes | 1 | 1993 | 136 | 0.020 |
Why?
| | Software | 1 | 2016 | 608 | 0.020 |
Why?
| | Disease Progression | 1 | 2018 | 2628 | 0.020 |
Why?
| | Attitude of Health Personnel | 1 | 2018 | 1102 | 0.020 |
Why?
| | Reproducibility of Results | 2 | 2009 | 3081 | 0.020 |
Why?
| | Pleasure | 1 | 2010 | 21 | 0.020 |
Why?
| | Sensation | 1 | 2010 | 51 | 0.020 |
Why?
| | Chromatography, Gas | 1 | 1990 | 32 | 0.020 |
Why?
| | Exercise | 1 | 2021 | 1931 | 0.020 |
Why?
| | Prognosis | 1 | 2018 | 3772 | 0.020 |
Why?
| | Rats, Inbred Strains | 1 | 1990 | 367 | 0.020 |
Why?
| | Membrane Proteins | 1 | 2016 | 1118 | 0.020 |
Why?
| | Cooperative Behavior | 1 | 2012 | 432 | 0.020 |
Why?
| | Patient Discharge | 1 | 2016 | 854 | 0.020 |
Why?
| | Negotiating | 1 | 2009 | 30 | 0.020 |
Why?
| | Psychological Tests | 1 | 2010 | 135 | 0.020 |
Why?
| | Molecular Structure | 1 | 1990 | 482 | 0.020 |
Why?
| | Epistasis, Genetic | 1 | 2009 | 70 | 0.020 |
Why?
| | Personality Inventory | 1 | 2009 | 139 | 0.020 |
Why?
| | Mouth Mucosa | 1 | 2007 | 89 | 0.020 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 952 | 0.020 |
Why?
| | Parent-Child Relations | 1 | 2009 | 258 | 0.020 |
Why?
| | Odds Ratio | 1 | 2009 | 1018 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2009 | 1286 | 0.020 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2008 | 754 | 0.020 |
Why?
| | Rats | 2 | 1993 | 5470 | 0.020 |
Why?
| | Linear Models | 1 | 2007 | 818 | 0.010 |
Why?
| | Reference Values | 1 | 2006 | 795 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2016 | 7052 | 0.010 |
Why?
| | Research Design | 1 | 2009 | 1043 | 0.010 |
Why?
| | Frontal Lobe | 1 | 2004 | 154 | 0.010 |
Why?
| | Dopamine Plasma Membrane Transport Proteins | 1 | 2003 | 47 | 0.010 |
Why?
| | Chi-Square Distribution | 1 | 2004 | 515 | 0.010 |
Why?
| | Schools | 1 | 2006 | 439 | 0.010 |
Why?
| | Housing | 1 | 2004 | 130 | 0.010 |
Why?
| | Family Characteristics | 1 | 2004 | 180 | 0.010 |
Why?
| | Attention | 1 | 2004 | 439 | 0.010 |
Why?
| | Algorithms | 1 | 2008 | 1614 | 0.010 |
Why?
| | Transcription, Genetic | 1 | 2007 | 1416 | 0.010 |
Why?
| | DNA | 1 | 2007 | 1400 | 0.010 |
Why?
| | Cognition Disorders | 1 | 2003 | 505 | 0.010 |
Why?
| | Double-Blind Method | 1 | 2003 | 1873 | 0.010 |
Why?
| | Arsenates | 1 | 1993 | 1 | 0.010 |
Why?
| | Unithiol | 1 | 1993 | 2 | 0.010 |
Why?
| | Dimercaprol | 1 | 1993 | 6 | 0.010 |
Why?
| | Succimer | 1 | 1993 | 4 | 0.010 |
Why?
| | Drug Evaluation, Preclinical | 1 | 1993 | 171 | 0.010 |
Why?
| | Arsenic | 1 | 1993 | 63 | 0.010 |
Why?
| | Mice, Inbred Strains | 1 | 1993 | 408 | 0.010 |
Why?
| | Animals | 2 | 1993 | 35334 | 0.010 |
Why?
| | In Vitro Techniques | 1 | 1993 | 1091 | 0.010 |
Why?
| | Rats, Sprague-Dawley | 1 | 1993 | 2393 | 0.000 |
Why?
| | Mice | 1 | 1993 | 16973 | 0.000 |
Why?
|
|
Hopfer's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|